OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Bioavailability of Drugs—The Current State of Knowledge
Marlena Stielow, Adrianna Witczyńska, Natalia Kubryń, et al.
Molecules (2023) Vol. 28, Iss. 24, pp. 8038-8038
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

Chitosan: An overview of biological activities, derivatives, properties, and current advancements in biomedical applications
Great Iruoghene Edo, Emad͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏ Yousif, Mohammed H. Al‐Mashhadani
Carbohydrate Research (2024) Vol. 542, pp. 109199-109199
Closed Access | Times Cited: 23

Chitosan: An Overview of Its Properties, Solubility, Functional Technologies, Food and Health Applications.
Great Iruoghene Edo, Winifred Ndudi, Ali B. M. Ali, et al.
Carbohydrate Research (2025) Vol. 550, pp. 109409-109409
Closed Access | Times Cited: 1

Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer
Prachi Bajpai, Sumit Agarwal, Farrukh Afaq, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 7

Advances in Intrathecal Nanoparticle Delivery: Targeting the Blood–Cerebrospinal Fluid Barrier for Enhanced CNS Drug Delivery
Ahmad Khalid Madadi, Moon‐Jun Sohn
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1070-1070
Open Access | Times Cited: 7

A Computational Study of New Glitazones‐Sulphonylureas Hybrids as Potential Antidiabetic Agents
Kabelo Phuti Mokgopa, Adedapo S. Adeyinka, Simon S. Mnyakeni‐Moleele, et al.
ChemistrySelect (2025) Vol. 10, Iss. 3
Open Access

Bioavailability and dose proportionality of a highly lipophilic phenolic antioxidant
E. A. Yanovskaya, Galina A. Frelikh, A. P. Lakeev, et al.
Xenobiotica (2025), pp. 1-33
Closed Access

Clinical and Hypothetical Cases of Drug and Non-drug Interactions
John I. Ogbu, Caroline Vitória de Lima Moreira, Adedunni Olusanya, et al.
(2025), pp. 233-259
Closed Access

Electrophilic Compounds in the Human Diet and Their Role in the Induction of the Transcription Factor NRF2
Celia María Curieses Andrés, José Manuel Pérez de la Lastra, Elena Bustamante Munguira, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3521-3521
Open Access | Times Cited: 6

Enhancing the Solubility and Dissolution of Apigenin: Solid Dispersions Approach
Natalia Rosiak, Ewa Tykarska, Andrzej Miklaszewski, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 566-566
Open Access

The Pharmacological and Clinical Roles of Antiemetics: A Narrative Review
Alan D. Kaye, Donovan B Turpin, Shivam Shah, et al.
Cureus (2025)
Open Access

Microbial-based natural products as potential inhibitors targeting DNA gyrase B of Mycobacterium tuberculosis: an in silico study
Tilal Elsaman, Magdi Awadalla Mohamed, Malik Suliman Mohamed, et al.
Frontiers in Chemistry (2025) Vol. 13
Open Access

Current Advances in the Therapeutic Potential of Scutellarin: Novel Applications, Mechanisms, and Future Challenges.
Great Iruoghene Edo, Alice Njolke Mafe, Patrick Othuke Akpoghelie, et al.
Phytomedicine Plus (2025), pp. 100754-100754
Open Access

Administration route-dependent pharmacokinetic and biopharmaceutical features of steppogenin
Ji‐Hoon Lee, Minyeong Pang, So Yeon Jeon, et al.
Journal of Pharmaceutical Investigation (2025)
Closed Access

Natural drug delivery systems for the treatment of neurodegenerative diseases
Greta Kaspute, Arūnas Ramanavičius, Urtė Prentice
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access

In silico Repurposing of FDA-Approved Drugs as Multi-target Inhibitors of Glioblastoma
Ridwan Abiodun Salaam, Funmilayo I. D. Afolayan, Damilare Adebayo Olaniyi, et al.
Scientific African (2025), pp. e02582-e02582
Open Access

Microbiome Integrity Enhances the Efficacy and Safety of Anticancer Drug
Alice Njolke Mafe, Dietrich Büsselberg
Biomedicines (2025) Vol. 13, Iss. 2, pp. 422-422
Open Access

Luteolin in Inflammatory Bowel Disease and Colorectal Cancer: A Disease Continuum Perspective
Fang Liu, Cui Guo, Xue Liu, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 126-126
Open Access

Addressing the global challenge of bacterial drug resistance: insights, strategies, and future directions
Arun Karnwal, Amar Yasser Jassim, Ameer A. Mohammed, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access

Oxalis corniculata‐Derived Bioactive Compounds Target Hormone Receptors in Breast Cancer: HPLC‐ESI‐MS/MS Analysis, Cytotoxicity, and Computational Studies
Tanveer Ahamad, Mohsin Ali Khan, Mohd Faheem Khan, et al.
ChemistrySelect (2025) Vol. 10, Iss. 8
Closed Access

Potential of capsaicin as a combinatorial agent to overcome chemoresistance and to improve outcomes of cancer therapy
Bethsebie Lalduhsaki Sailo, Anushka Garhwal, Abinash Mishra, et al.
Biochemical Pharmacology (2025), pp. 116828-116828
Open Access

Common Drug-Drug and Drug-Food Interactions in Antineoplastic Agents: A short update review
Sonia Sanajou, Terken Baydar
Hacettepe University Journal of the Faculty of Pharmacy (2025) Vol. 45, Iss. 1, pp. 92-105
Closed Access

Using Immunoliposomes as Carriers to Enhance the Therapeutic Effectiveness of Macamide N-3-Methoxybenzyl-Linoleamide
Karin J. Vera-López, María Aranzamendi-Zenteno, Gonzalo Dávila-Del-Carpio, et al.
Neurology International (2025) Vol. 17, Iss. 3, pp. 38-38
Open Access

Page 1 - Next Page

Scroll to top